Zinc finger protein 316 (ZNF316)

Zinc finger protein 316 (ZNF316) is a human protein encoded by the ZNF316 gene located on chromosome 7. It is predicted to be a DNA-binding transcription factor that regulates gene expression through sequence-specific DNA binding and may act in the nucleus in concert with RNA polymerase II. ZNF316 belongs to the C2H2-type zinc finger protein family—the largest family of transcription factors in the human genome—known for their roles in numerous cellular processes including gene regulation, development, apoptosis, and immune responses. Transcription factors like ZNF316 act by binding to DNA in a sequence-specific manner, often regulating the expression of multiple genes. Though the zinc finger protein family is a well-known subject in cancer and developmental biology, the function of many individual members—including ZNF316—remains incompletely characterized. Importantly, there is no published evidence directly connecting ZNF316 to drug interactions, clinical biomarkers, or therapeutic targeting. While zinc finger proteins broadly are implicated in diseases such as cancer, there are no clear disease associations, safety concerns, or therapeutic applications reported specifically for ZNF316. It is not considered a therapeutic target, nor is it listed as a biomarker or associated with notable safety concerns. Most available information applies to the general zinc finger protein family, not uniquely to ZNF316.

Other names

ZNF316MZF-3ENST00000305834zinc finger protein 316